SCHEDULE 13G/A
0000019617
XXXXXXXX
LIVE
1
Common Stock, $0.0001 par value per share
04/30/2025
0001664710
KEROS THERAPEUTICS, INC.
492327101
1050 Waltham Street
Suite 302
Lexington
MA
02421
Rule 13d-1(b)
JPMORGAN CHASE & CO.
DE
113803.0
0.0
113803.0
0.0
113803.0
N
0.2
HC
KEROS THERAPEUTICS, INC.
1050 Waltham Street Suite 302 Lexington MA 02421
JPMORGAN CHASE & CO.
383 Madison Avenue,, New York, NY 10179
DE
N
HC
113803
0.2
113803
0
113803
0
N
Y
N
Not Applicable
N
J.P. Morgan Securities LLC; JPMorgan Chase Bank, National Association; J.P. Morgan Markets Limited
N
Not Applicable
N
Not Applicable
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
JPMORGAN CHASE & CO.
Rachel Tsvaygoft
Vice President
05/05/2025
primary_doc.xml